You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Circularity and Value Extension of CarbonCycle Waste-To-Value Thermal Conversion Process
SBC: CARBONCYCLE LLC Topic: AF20CTCSO1CarbonCycle is a Waste to Value company. We have developed a system that converts carbon-based waste—scrap tires, mixed plastics, used oil, bio-waste, paper, and wood (to name a few)—into valuable and usable products via our proprietary Advanced Pyrolysis
STTR Phase II 2021 Department of DefenseAir Force -
Furthering Circular Economy Potential of Waste-to-Value Process Through Product Development
SBC: CARBONCYCLE LLC Topic: AF20CTCSO1CarbonCycle is a Waste to Value company. We have developed a system that converts carbon-based waste—scrap tires, mixed plastics, used oil, bio-waste, paper, and wood (to name a few)—into valuable and usable products via our proprietary Advanced Pyrolysis technology. Our system implements a closed loop solution, creating valuable, reusable carbon and oil based products through thermal conversi ...
STTR Phase I 2021 Department of DefenseAir Force -
Rapid handheld SARS-CoV-2 surface sterilization device using high-power UVC-LED arrays
SBC: NITRIDE SOLUTIONS, INC. Topic: AF20CTCSO1Nitride Solutions intends to determine the commercial and technical feasibility for design of UV-C LED components for disinfection of SARS-CoV-2 for commercial, industrial and military uses. We believe that UV-C LEDs are the best sterilization solution for aerosol spread onto surfaces. NSI will use its expertise in UV-C LEDS, optical design and reflective materials to develop an optimum power and ...
STTR Phase I 2021 Department of DefenseAir Force -
Novel Pulsed RF Energy for USAF Applications
SBC: KALSCOTT ENGINEERING INC. Topic: AF21ATCSO1This project aims at developing an optimally designed pulsed power radiating system for wireless power transfer over medium to extremely long distances in the microwave frequency region. Such radiating systems may also be used for wireless power transfer
STTR Phase I 2021 Department of DefenseAir Force -
Gamifying Cybersecurity to Eliminate Analyst Alert Fatigue
SBC: KANSHI LLC Topic: AF21ATCSO1Alert fatigue is a major pain point for cybersecurity organizations today. Analysts are constantly overwhelmed by cybersecurity alerts leading to disinterest, boredom, and misclassifications (false negative and missed incidents) due to the resulting fatigue. Failing success with automation, many organizations have resorted to turning off high-volume events to minimize the effects of alert fatigue ...
STTR Phase I 2021 Department of DefenseAir Force -
Preclinical Development of ACXT-3102 for the Treatment of Pancreatic Adenocarcinoma (PDAC)
SBC: Accuronix Therapeutics Inc Topic: 102Project Summary/Abstract Pancreatic cancer is a devastating disease with a very low (8%) 5-year survival rate. Therapeutic options are limited in efficacy and many have substantial toxicity. Targeted drug delivery may improve the therapeutic index of cancer drugs by enhancing drug localization to the cancer cell while minimizing off-target side effects. Sigma-2 receptors (S2R) are highly expressed ...
STTR Phase II 2021 Department of Health and Human ServicesNational Institutes of Health -
Mitofusin agonists to prevent Charcot-Marie-Tooth disease 2A
SBC: Mitochondria in Motion, Inc. Topic: NINDSMitofusin agonists to prevent Charcot-Marie-Tooth disease 2A Gerald W Dorn II, MD Mitochondria in Motion, Inc. Washington University in St Louis School of Medicine Abstract: Charcot-Marie-Tooth (CMT) disease type 2A is an incurable, primarily pediatric, autosomal dominant neuromuscular degenerative disease caused by mutations in the mitofusin (MFN) 2 gene. There are currently no disease-altering t ...
STTR Phase II 2021 Department of Health and Human ServicesNational Institutes of Health -
Super-resolution dual-energy dental CT based on distributed x-ray source and photon counting detector
SBC: TETRAIMAGING LLC Topic: NIDCRABSTRACT With cone-beam CTandapos;s introduction in dentistry, dental clinicians could not only have profound knowledge of oral pathology but could also enhance the access to a detailed view of the underlying structures and their relations. Dental CBCT could be justified for presurgical diagnosis, preoperative planning and preoperative transfer for oral implant rehabilitation. The image quality of ...
STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health -
Suramin for Recluse Spider Bites
SBC: STOECKER MD, WILLIAM V Topic: NIAMSSuramin for Recluse Spider Bites: SpiderTek, a biotechnology company that developed the first spider bite diagnostic test, proposes therapy for bites due to Loxoscelesthre erecclulseusspiade,r, using suramin, a century-old treatment for African sleeping sickness. A population of 80 million in the South-Central US shares homes with the recluse spider. Each year, an estimated 30,000 persons suffer r ...
STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health -
Isovolumetric Multimodal Venous Thrombectomy System
SBC: Caeli Vascular LLC Topic: NHLBIABSTRACTThis Phase II STTR application from Caeli Vascular, LLC entails a 24-month period focused on further development of a novel multi-modal venous thrombectomy device. The PI is a vascular surgeon with biomedical research and entrepreneurship experience, and is supported by a team of highly qualified investigators, including a vascular biologist, neurosurgeon, veterinarian, biomedical engineer ...
STTR Phase II 2021 Department of Health and Human ServicesNational Institutes of Health